Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. A Retrospective Comparison of 3-Factor Prothrombin Complex Concentrate Products for Warfarin Reversal.The Neurohospitalist · 2020
   Article
2. Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer.Internal and emergency medicine · 2019
   Review
3. A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2017
   Review
4. 3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter, Retrospective, Propensity-Matched Pilot Study.Journal of thrombosis and thrombolysis · 2016
   Article
5. Evaluation of a fixed, weight-based dose of 3-factor prothrombin complex concentrate without adjunctive plasma following warfarin-associated intracranial hemorrhage.Neurocritical care · 2014
   Article
6. Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal.World journal of emergency surgery : WJES · 2014
   Article
7. Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.Blood transfusion = Trasfusione del sangue · 2013
   Article
8. Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.Journal of neurology · 2013
   Observational
9. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.Critical care (London, England) · 2012
   Observational
10. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.Blood transfusion = Trasfusione del sangue · 2012
    Article
11. Three- or four-factor prothrombin complex concentrate for emergency anticoagulation reversal: what are we really looking for?Blood transfusion = Trasfusione del sangue · 2011
    Article

Corrections and comments

• Commented on by
  Three- or four-factor prothrombin complex concentrate for emergency anticoagulation reversal: what are we really looking for?2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as